


Searching News Database: Hackensack University Medical Center
HSMN NewsFeed - 13 Feb 2018
Abiomed Receives Approval for Expanded FDA Indication for Cardiomyopathy with Cardiogenic Shock
Abiomed Receives Approval for Expanded FDA Indication for Cardiomyopathy with Cardiogenic Shock
HSMN NewsFeed - 13 Feb 2014
MYOS Corporation Announces Appointment of Robert C. Ashton, Jr., M.D., as Chief Medical Officer
MYOS Corporation Announces Appointment of Robert C. Ashton, Jr., M.D., as Chief Medical Officer
HSMN NewsFeed - 20 Jul 2012
Onyx Pharmaceuticals Receives FDA Accelerated Approval of Kyprolis(TM) (carfilzomib) for Injection
Onyx Pharmaceuticals Receives FDA Accelerated Approval of Kyprolis(TM) (carfilzomib) for Injection
HSMN NewsFeed - 13 Jul 2012
Hackensack University Medical Center At Pascack Valley Appoints Healthcare Veteran Chad Melton As New CEO
Hackensack University Medical Center At Pascack Valley Appoints Healthcare Veteran Chad Melton As New CEO
HSMN NewsFeed - 17 May 2010
John Theurer Cancer Center Offers Breakthrough Radiation Measurement Technology
John Theurer Cancer Center Offers Breakthrough Radiation Measurement Technology
HSMN NewsFeed - 30 Jan 2007
TetraLogic Pharmaceuticals Appoints Dr. Andrew Pecora to Its Board of Directors
TetraLogic Pharmaceuticals Appoints Dr. Andrew Pecora to Its Board of Directors
HSMN NewsFeed - 8 Dec 2006
FDA Approves VELCADE(R) (Bortezomib) for Injection for Aggressive Form of Non-Hodgkin's Lymphoma
FDA Approves VELCADE(R) (Bortezomib) for Injection for Aggressive Form of Non-Hodgkin's Lymphoma
Additional items found! 7
Members Archive contains
7 additional stories matching:
Hackensack University Medical Center
(Password required)
Hackensack University Medical Center
(Password required)
